Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit Hedgehog signaling. Also described herein are methods for using such Hedgehog signaling inhibitors, alone or in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of Hedgehog signaling.
Type:
Grant
Filed:
October 25, 2016
Date of Patent:
December 22, 2020
Assignee:
MAX BIOPHARMA, INC.
Inventors:
Frank Stappenbeck, Yi Chiao Fan, Feng Wang, Farhad Parhami
Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit Hedgehog signaling. Also described herein are methods for using such Hedgehog signaling inhibitors, alone or in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of Hedgehog signaling.
© 2024 Justia
